Class Notes (1,100,000)
CA (620,000)
Western (60,000)
HS (2,000)
Lecture 7

Health Sciences 1002A/B Lecture Notes - Lecture 7: Female Sexual Arousal Disorder, Medicalization, Prescription Drug


Department
Health Sciences
Course Code
HS 1002A/B
Professor
Jessica Polzer
Lecture
7

This preview shows half of the first page. to view the full 2 pages of the document.
F e b 1 1 | 1
Orgasm, Inc., lm
FSD: female sexual dysfuncon
How drug companies created the disease to make prot, and scared the public to think there
was something wrong with them in the process.
1. Where did the denion of FSD come from? Who shaped this denion?
-One theory says that women have increased social pressure to have an orgasm every
me they have sex. But they didn’t get orgasms each me, especially at old age, when
they thought they should get the same orgasms they got at 25. Women thought that
there was something wrong with them. Drug companies saw this as potenal to
introduce a drug to help women have be+er orgasms. They pushed the FDA to register
FSD as an actual disorder, for this is required for the companies to try develop drugs.
-In this manner, drug companies created the disorder female sexual dysfuncon, and
made a lot of money o/ this.
-By adversing FSD to the public, women felt that there was something wrong with them.
The public manipulated this informaon and nervously overreacted to the disorder as a
result of shows like Oprah Winfrys. Public were manipulated by an old inadequate
stasc, that said ‘43% of people su/er from FSD,’ because of things like ‘they
somemes became anxious before having sex.’ This could be because they had
relaonship issues with their partner. Also, this study was sponsored by FSD drug
developing companies.
2. What sites of medicalizaon can you idenfy in the lm? That is, where do
construcons of FSD emerge and through what processes?
-Hysteria used to be considered a disease about 100 years ago, and is no longer thought
of one. Doctors would treat this disease with vibrators, where they would smulate an
orgasm in the women. It was ‘medicalized’ by doctors at the me, similar to the way
‘FSD’ is medicalized now.
3. Who benets from the medicalizaon of female sexuality? Who loose? What do you
think about this?
-Drug companies, drug company promoters, and a7liated medical personnel benet for
they make lots of money. The general public looses for they feel scared that they are
abnormal, and frustrated that there is something wrong with them. This leads to
decreased self esteem.
-Interesng stasc:
oClinical trials funded by pharmaceucal trials have 3-5x the likelihood of
determining the drugs success than independent studies.
oThe U.S. makes about 5% of the world’s populaon and accounts for about 42%
of the worlds prescripon drug use….
-Insights:
oWomen thought that there was something wrong with them because they
couldn’t achieve an orgasm the way they thought people were supposed to.
Media may have played a role in this, through the relavely new popularity of
pornography in our generaon.
oWhy do drug trials sponsored by drug companies wok be+er than non-a7liated
ones, even though they both follow strict research guidelines? Its possible this
You're Reading a Preview

Unlock to view full version